{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:05Z","timestamp":1779430145599,"version":"3.53.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00417-026-07164-w","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:10:08Z","timestamp":1772169008000},"page":"1559-1577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Origin, diagnosis and treatment of periocular Histiocytic disorders\u2013 state-of-the-art review"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1761-248X","authenticated-orcid":false,"given":"Munazzah Rifat","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Vahdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Harding","family":"Verity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey Edward","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"22","key":"7164_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Freitag S, Horne A, Haroche J, Donadieu J et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"issue":"5","key":"7164_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/bjh.18459","volume":"199","author":"H Liu","year":"2022","unstructured":"Liu H, Stiller CA, Crooks CJ, Rous B, Bythell M, Broggio J et al (2022) Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: a national registry study from England, 2013\u20132019. Br J Haematol 199(5):728\u201338. https:\/\/doi.org\/10.1111\/bjh.18459","journal-title":"Br J Haematol"},{"key":"7164_CR3","doi-asserted-by":"crossref","unstructured":"Verity DH, Vahdani K, Rose GE (2024) Histiocytic disease of the orbit. In: Quaranta Leoni FM, Verity DH, Paridaens D (eds) Oculoplastic, lacrimal and orbital surgery. The ESOPRS textbook. Springer Nature, pp 253\u2013281","DOI":"10.1007\/978-3-031-39638-0_20"},{"key":"7164_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563\u2013604. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074950","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"7164_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML et al (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919\u201323. https:\/\/doi.org\/10.1182\/blood-2010-04-279083","journal-title":"Blood"},{"issue":"5","key":"7164_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.hoc.2015.06.004","volume":"29","author":"BJ Rollins","year":"2015","unstructured":"Rollins BJ (2015) Genomic alterations in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 29(5):839\u2013851. https:\/\/doi.org\/10.1016\/j.hoc.2015.06.004","journal-title":"Hematol Oncol Clin North Am"},{"issue":"21","key":"7164_CR7","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","volume":"128","author":"R Chakraborty","year":"2016","unstructured":"Chakraborty R, Burke TM, Hampton OA, Zinn DJ, Lim KP, Abhyankar H et al (2016) Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood 128(21):2533\u20137","journal-title":"Blood"},{"issue":"6892","key":"7164_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u201354. https:\/\/doi.org\/10.1038\/nature00766","journal-title":"Nature"},{"issue":"2","key":"7164_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA et al (2016) Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6(2):154\u201365. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0913","journal-title":"Cancer Discov"},{"issue":"3","key":"7164_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89473","volume":"2","author":"LH Lee","year":"2017","unstructured":"Lee LH, Gasilina A, Roychoudhury J, Clark J, McCormack FX, Pressey J et al (2017) Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes. JCI Insight 2(3):e89473. https:\/\/doi.org\/10.1172\/jci.insight.89473","journal-title":"JCI Insight"},{"issue":"7","key":"7164_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","volume":"124","author":"B Hervier","year":"2014","unstructured":"Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Neel A et al (2014) Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood 124(7):1119\u201326","journal-title":"Blood"},{"issue":"9","key":"7164_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/modpathol.2017.50","volume":"30","author":"CN Paxton","year":"2017","unstructured":"Paxton CN, O\u2019Malley DP, Bellizzi AM, Alkapalan D, Fedoriw Y, Hornick JL et al (2017) Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases May show more complexity. Mod Pathol 30(9):1234\u20131240. https:\/\/doi.org\/10.1038\/modpathol.2017.50","journal-title":"Mod Pathol"},{"issue":"3","key":"7164_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.det.2015.03.010","volume":"33","author":"J Kerstetter","year":"2015","unstructured":"Kerstetter J, Wang J (2015) Adult orbital xanthogranulomatous disease: a review with emphasis on etiology, systemic associations, diagnostic tools, and treatment. Dermatol Clin 33(3):457\u2013463. https:\/\/doi.org\/10.1016\/j.det.2015.03.010","journal-title":"Dermatol Clin"},{"issue":"12","key":"7164_CR14","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1001\/jamaoncol.2022.4432","volume":"8","author":"JP Abeykoon","year":"2022","unstructured":"Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S et al (2022) <article-title update=\"added\"> Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status. JAMA Oncol 8(12):1816\u20131820. https:\/\/doi.org\/10.1001\/jamaoncol.2022.4432","journal-title":"JAMA Oncol"},{"issue":"3","key":"7164_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hoc.2025.02.002","volume":"39","author":"K Zhang","year":"2025","unstructured":"Zhang K, Meyer LK, Machowicz R, Coniglio ML, Sieni E, Nichols KE (2025) Genetics of familial hemophagocytic lymphohistiocytosis (HLH). Hematol Oncol Clin North Am 39(3):531\u2013551. https:\/\/doi.org\/10.1016\/j.hoc.2025.02.002","journal-title":"Hematol Oncol Clin North Am"},{"issue":"23","key":"7164_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N et al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133(23):2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"issue":"5","key":"7164_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ajh.27263","volume":"99","author":"GJ Ruan","year":"2024","unstructured":"Ruan GJ, Zanwar S, Ravindran A, Schram S, Abeykoon JP, Hazim A et al (2024) Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis. Am J Hematol 99(5):871\u20139. https:\/\/doi.org\/10.1002\/ajh.27263","journal-title":"Am J Hematol"},{"issue":"6","key":"7164_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/01.IOP.0000092800.86282.27","volume":"19","author":"KI Woo","year":"2003","unstructured":"Woo KI, Harris GJ (2003) Eosinophilic granuloma of the orbit: understanding the paradox of aggressive destruction responsive to minimal intervention. Ophthalmic Plast Reconstr Surg 19(6):429\u2013439. https:\/\/doi.org\/10.1097\/01.IOP.0000092800.86282.27","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"7164_CR19","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1001\/archopht.1980.01020040666015","volume":"98","author":"FA Jakobiec","year":"1980","unstructured":"Jakobiec FA, Trokel SL, Aron-Rosa D, Iwamoto T, Doyon D (1980) Localized eosinophilic granuloma (Langerhans\u2019 cell histiocytosis) of the orbital frontal bone. Arch Ophthalmol 98(10):1814\u20131820. https:\/\/doi.org\/10.1001\/archopht.1980.01020040666015","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"7164_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ijrobp.2017.10.053","volume":"100","author":"J Laird","year":"2018","unstructured":"Laird J, Ma J, Chau K, Chelius M, Shi W, Zhang Z et al (2018) Outcome after radiation therapy for Langerhans cell histiocytosis is dependent on site of involvement. Int J Radiat Oncol Biol Phys 100(3):670\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.10.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"7164_CR21","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1097\/IOP.0000000000000289","volume":"32","author":"MB Kashkouli","year":"2016","unstructured":"Kashkouli MB, Shahrzad S (2016) Intralesional injection of interferon-alpha2b in orbital eosinophilic granuloma. Ophthalmic Plast Reconstr Surg 32(5):e106\u2013e109. https:\/\/doi.org\/10.1097\/IOP.0000000000000289","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"7164_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1067\/mpd.2001.111331","volume":"138","author":"H Gadner","year":"2001","unstructured":"Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A et al (2001) A randomized trial of treatment for multisystem Langerhans\u2019 cell histiocytosis. J Pediatr 138(5):728\u201334. https:\/\/doi.org\/10.1067\/mpd.2001.111331","journal-title":"J Pediatr"},{"issue":"31","key":"7164_CR23","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1200\/JCO.19.00456","volume":"37","author":"J Donadieu","year":"2019","unstructured":"Donadieu J, Larabi IA, Tardieu M, Visser J, Hutter C, Sieni E et al (2019) Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study. J Clin Oncol 37(31):2857\u201365. https:\/\/doi.org\/10.1200\/JCO.19.00456","journal-title":"J Clin Oncol"},{"issue":"1","key":"7164_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4143\/crt.2020.769","volume":"53","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wang D, Cui L, Ma HH, Zhang L, Lian HY et al (2021) Effectiveness and safety of Dabrafenib in the treatment of 20 Chinese children with BRAFV600E-mutated Langerhans cell histiocytosis. Cancer Res Treat 53(1):261\u20139. https:\/\/doi.org\/10.4143\/crt.2020.769","journal-title":"Cancer Res Treat"},{"issue":"17","key":"7164_CR25","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R et al (2022) International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139(17):2601\u201321. https:\/\/doi.org\/10.1182\/blood.2021014343","journal-title":"Blood"},{"issue":"4","key":"7164_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjh.14818","volume":"182","author":"G Goyal","year":"2018","unstructured":"Goyal G, Shah MV, Hook CC, Wolanskyj AP, Call TG, Rech KL et al (2018) Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes. Br J Haematol 182(4):579\u201381. https:\/\/doi.org\/10.1111\/bjh.14818","journal-title":"Br J Haematol"},{"issue":"4","key":"7164_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"EL Diamond","year":"2014","unstructured":"Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124(4):483\u2013492","journal-title":"Blood"},{"issue":"2","key":"7164_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jbspin.2012.07.005","volume":"80","author":"O Aubert","year":"2013","unstructured":"Aubert O, Aouba A, Deshayes S, Georgin-Lavialle S, Rieu P, Hermine O (2013) Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with Anakinra. Joint Bone Spine 80(2):206\u2013207. https:\/\/doi.org\/10.1016\/j.jbspin.2012.07.005","journal-title":"Joint Bone Spine"},{"issue":"3","key":"7164_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","volume":"4","author":"EL Diamond","year":"2018","unstructured":"Diamond EL, Subbiah V, Lockhart AC, Blay JY, Puzanov I, Chau I et al (2018) Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncol 4(3):384\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5029","journal-title":"JAMA Oncol"},{"issue":"1","key":"7164_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/bjh.14284","volume":"180","author":"F Cohen Aubart","year":"2018","unstructured":"Cohen Aubart F, Emile JF, Maksud P, Galanaud D, Cluzel P, Benameur N et al (2018) Efficacy of the MEK inhibitor Cobimetinib for wild-type BRAF Erdheim-Chester disease. Br J Haematol 180(1):150\u2013153. https:\/\/doi.org\/10.1111\/bjh.14284","journal-title":"Br J Haematol"},{"issue":"11","key":"7164_CR31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/thorax.58.11.1004","volume":"58","author":"SC Bourke","year":"2003","unstructured":"Bourke SC, Nicholson AG, Gibson GJ (2003) Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 58(11):1004\u20131005","journal-title":"Thorax"},{"issue":"1","key":"7164_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10067-003-0801-7","volume":"23","author":"MC Jendro","year":"2004","unstructured":"Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A (2004) Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 23(1):52\u201356","journal-title":"Clin Rheumatol"},{"issue":"3","key":"7164_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/bjo.84.3.251","volume":"84","author":"KA Miszkiel","year":"2000","unstructured":"Miszkiel KA, Sohaib SA, Rose GE, Cree IA, Moseley IF (2000) Radiological and clinicopathological features of orbital Xanthogranuloma. Br J Ophthalmol 84(3):251\u2013258. https:\/\/doi.org\/10.1136\/bjo.84.3.251","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"7164_CR34","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.ophtha.2015.06.009","volume":"122","author":"WA Samara","year":"2015","unstructured":"Samara WA, Khoo CT, Say EA, Saktanasate J, Eagle RC Jr., Shields JA et al (2015) Juvenile Xanthogranuloma involving the eye and ocular adnexa: tumor control, visual outcomes, and Globe salvage in 30 patients. Ophthalmology 122(10):2130\u20132138. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.009","journal-title":"Ophthalmology"},{"issue":"5","key":"7164_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/01.IOP.0000083642.15174.83","volume":"19","author":"ZA Karcioglu","year":"2003","unstructured":"Karcioglu ZA, Sharara N, Boles TL, Nasr AM (2003) Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthalmic Plast Reconstr Surg 19(5):372\u2013381. https:\/\/doi.org\/10.1097\/01.IOP.0000083642.15174.83","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"7164_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200305000-00003","volume":"27","author":"LP Dehner","year":"2003","unstructured":"Dehner LP (2003) Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 27(5):579\u2013593. https:\/\/doi.org\/10.1097\/00000478-200305000-00003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"7164_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/bjo.75.11.680","volume":"75","author":"GE Rose","year":"1991","unstructured":"Rose GE, Patel BC, Garner A, Wright JE (1991) Orbital Xanthogranuloma in adults. Br J Ophthalmol 75(11):680\u2013684. https:\/\/doi.org\/10.1136\/bjo.75.11.680","journal-title":"Br J Ophthalmol"},{"key":"7164_CR38","first-page":"99","volume":"91","author":"FA Jakobiec","year":"1993","unstructured":"Jakobiec FA, Mills MD, Hidayat AA, Dallow RL, Townsend DJ, Brinker EA et al (1993) Periocular xanthogranulomas associated with severe adult-onset asthma. Trans Am Ophthalmol Soc 91:99\u2013125 discussion\u2009\u2013\u20099. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1298462\/","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"8","key":"7164_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/bjo.2006.107821","volume":"91","author":"CI Zoumalan","year":"2007","unstructured":"Zoumalan CI, Erb MH, Rao NA, See R, Bernstine MA, Shah SB et al (2007) Periorbital Xanthogranuloma after blepharoplasty. Br J Ophthalmol 91(8):1088\u20131089. https:\/\/doi.org\/10.1136\/bjo.2006.107821","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7164_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s0002-9394(99)00469-9","volume":"129","author":"S Ugurlu","year":"2000","unstructured":"Ugurlu S, Bartley GB, Gibson LE (2000) Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 129(5):651\u2013657. https:\/\/doi.org\/10.1016\/s0002-9394(99)00469-9","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"7164_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s0002-9394(99)00469-9","volume":"156","author":"CA Nelson","year":"2020","unstructured":"Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH et al (2020) A multicenter cross-sectional study and systematic review of necrobiotic Xanthogranuloma with proposed diagnostic criteria. JAMA Dermatol 156(3):270\u2013279. https:\/\/doi.org\/10.1016\/s0002-9394(99)00469-9","journal-title":"JAMA Dermatol"},{"issue":"2","key":"7164_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/01913128109064239","volume":"2","author":"R Sanchez","year":"1981","unstructured":"Sanchez R, Sibley RK, Rosai J, Dorfman RF (1981) The electron microscopic features of sinus histiocytosis with massive lymphadenopathy: a study of 11 cases. Ultrastruct Pathol 2(2):101\u2013119. https:\/\/doi.org\/10.3109\/01913128109064239","journal-title":"Ultrastruct Pathol"},{"key":"7164_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2023.05.011","volume":"253","author":"L Wang","year":"2023","unstructured":"Wang L, Suo L, Kou F, Zhang Y, Li M, Wang H et al (2023) Ocular phenotypes in patients with hemophagocytic lymphohistiocytosis: a retrospective analysis in a single center over 7 years. Am J Ophthalmol 253:119\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2023.05.011","journal-title":"Am J Ophthalmol"},{"key":"7164_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.lrr.2017.11.003","volume":"9","author":"MB Abid","year":"2018","unstructured":"Abid MB, Wadera K, Bird JM, Pawade J, Marks DI (2018) Alemtuzumab-based therapy for secondary malignant histiocytosis arising from pre-B-ALL. Leuk Res 9:5\u20138. https:\/\/doi.org\/10.1016\/j.lrr.2017.11.003","journal-title":"Leuk Res"},{"issue":"2","key":"7164_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/s0889-8588(05)70517-7","volume":"12","author":"HS Nicholson","year":"1998","unstructured":"Nicholson HS, Egeler RM, Nesbit ME (1998) The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12(2):379-84.https:\/\/doi.org\/10.1016\/s0889-8588(05)70517-7","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"7164_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/mpo.1178","volume":"37","author":"C Titgemeyer","year":"2001","unstructured":"Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H (2001) Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 37(2):108\u201314. https:\/\/doi.org\/10.1002\/mpo.1178","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"7164_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ophtha.2003.01.002","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 111(5):997\u20131008. https:\/\/doi.org\/10.1016\/j.ophtha.2003.01.002","journal-title":"Ophthalmology"},{"issue":"1","key":"7164_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bjo.69.1.7","volume":"69","author":"AT Moore","year":"1985","unstructured":"Moore AT, Pritchard J, Taylor DS (1985) Histiocytosis X: an ophthalmological review. Br J Ophthalmol 69(1):7\u201314. https:\/\/doi.org\/10.1136\/bjo.69.1.7","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"7164_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0889-8588(05)70507-4","volume":"12","author":"L Schmitz","year":"1998","unstructured":"Schmitz L, Favara BE (1998) Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12(2):221-46.https:\/\/doi.org\/10.1016\/s0889-8588(05)70507-4","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"7164_CR50","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/s0161-6420(87)33352-4","volume":"94","author":"AT Glover","year":"1987","unstructured":"Glover AT, Grove AS Jr. (1987) Eosinophilic granuloma of the orbit with spontaneous healing. Ophthalmology 94(8):1008\u201312. https:\/\/doi.org\/10.1016\/s0161-6420(87)33352-4","journal-title":"Ophthalmology"},{"issue":"2","key":"7164_CR51","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ajo.2005.08.029","volume":"141","author":"GJ Harris","year":"2006","unstructured":"Harris GJ (2006) Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue. Am J Ophthalmol 141(2):374\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2005.08.029","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"7164_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bjh.13347","volume":"169","author":"PA Veys","year":"2015","unstructured":"Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A et al (2015) Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. Br J Haematol 169(5):711\u20138. https:\/\/doi.org\/10.1111\/bjh.13347","journal-title":"Br J Haematol"},{"issue":"7","key":"7164_CR53","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1111\/j.1651-2227.2010.02125.x","volume":"100","author":"D Gavhed","year":"2011","unstructured":"Gavhed D, Laurencikas E, Akefeldt SO, Henter JI (2011) Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis. Acta Paediatr 100(7):e36\u2013e39. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.02125.x","journal-title":"Acta Paediatr"},{"issue":"3","key":"7164_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","volume":"75","author":"C Veyssier-Belot","year":"1996","unstructured":"Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M et al (1996) Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75(3):157\u201369. https:\/\/doi.org\/10.1097\/00005792-199605000-00005","journal-title":"Medicine (Baltimore)"},{"key":"7164_CR55","first-page":"931","volume":"42","author":"JA Shields","year":"1990","unstructured":"Shields JA, Shields CL (1990) Clinical spectrum of Histiocytic tumors of the orbit. Trans Pa Acad Ophthalmol Otolaryngol 42:931\u2013937","journal-title":"Trans Pa Acad Ophthalmol Otolaryngol"},{"key":"7164_CR56","first-page":"64","volume":"81","author":"MG Alper","year":"1983","unstructured":"Alper MG, Zimmerman LE, Piana FG (1983) Orbital manifestations of Erdheim-Chester disease. Trans Am Ophthalmol Soc 81:64\u201385","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"7164_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30232","volume":"70","author":"T Zou","year":"2023","unstructured":"Zou T, Wei A, Ma H, Lian H, Liu Y, Wang D et al (2023) Systemic juvenile xanthogranuloma: a systematic review. Pediatr Blood Cancer 70(5):e30232. https:\/\/doi.org\/10.1002\/pbc.30232","journal-title":"Pediatr Blood Cancer"},{"issue":"10295","key":"7164_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(21)00311-1","volume":"398","author":"JF Emile","year":"2021","unstructured":"Emile JF, Cohen-Aubart F, Collin M, Freitag S, Idbaih A, Abdel-Wahab O et al (2021) Histiocytosis Lancet 398(10295):157\u2013170. https:\/\/doi.org\/10.1016\/S0140-6736(21)00311-1","journal-title":"Histiocytosis Lancet"},{"issue":"9","key":"7164_CR59","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/s0161-6420(86)33605-4","volume":"93","author":"JD Bullock","year":"1986","unstructured":"Bullock JD, Bartley GB, Campbell RJ, Yanes B, Connelly PJ, Funkhouser JW (1986) Necrobiotic Xanthogranuloma with paraproteinemia. Case report and a pathogenetic theory. Ophthalmology 93(9):1233\u20131236. https:\/\/doi.org\/10.1016\/s0161-6420(86)33605-4","journal-title":"Ophthalmology"},{"key":"7164_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110299","volume":"265","author":"SE Detiger","year":"2024","unstructured":"Detiger SE, Paridaens D, Kemps PG, van Halteren AGS, van Hagen PM, van Laar JAM et al (2024) Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations. Clin Immunol 265:110299. https:\/\/doi.org\/10.1016\/j.clim.2024.110299","journal-title":"Clin Immunol"},{"issue":"5","key":"7164_CR61","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1227\/00006123-199305000-00022","volume":"32","author":"O Vernet","year":"1993","unstructured":"Vernet O, Ducrey N, Deruaz JP, de Tribolet N (1993) Giant cell tumor of the orbit. Neurosurgery 32(5):848\u201351. https:\/\/doi.org\/10.1227\/00006123-199305000-00022","journal-title":"Neurosurgery"},{"key":"7164_CR62","doi-asserted-by":"publisher","unstructured":"Rosai J, Dorfman RF (1972) Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 30(5):1174\u201388. https:\/\/doi.org\/10.1002\/1097-0142(197211)30:5%3C;1174::aid-cncr2820300507%3E;3.0.co;2-s","DOI":"10.1002\/1097-0142(197211)30:5%3C;1174::aid-cncr2820300507%3E;3.0.co;2-s"},{"issue":"3","key":"7164_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0002-9394(79)90077-1","volume":"87","author":"E Foucar","year":"1979","unstructured":"Foucar E, Rosai J, Dorfman RF (1979) The ophthalmologic manifestations of sinus histiocytosis with massive lymphadenopathy. Am J Ophthalmol 87(3):354\u2013367. https:\/\/doi.org\/10.1016\/0002-9394(79)90077-1","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"7164_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.iop.0000217563.00975.a3","volume":"22","author":"Y Mohadjer","year":"2006","unstructured":"Mohadjer Y, Holds JB, Rootman J, Wilson MW, Gigantelli JW, Custer PL (2006) The spectrum of orbital Rosai-Dorfman disease. Ophthalmic Plast Reconstr Surg 22(3):163\u2013168. https:\/\/doi.org\/10.1097\/01.iop.0000217563.00975.a3","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"26","key":"7164_CR65","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF et al (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131(26):2877\u201390. https:\/\/doi.org\/10.1182\/blood-2018-03-839753","journal-title":"Blood"},{"key":"7164_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614704","volume":"12","author":"C Keenan","year":"2021","unstructured":"Keenan C, Nichols KE, Albeituni S (2021) Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis. Front Immunol 12:614704. https:\/\/doi.org\/10.3389\/fimmu.2021.614704","journal-title":"Front Immunol"},{"key":"7164_CR67","doi-asserted-by":"crossref","unstructured":"Rijal H, Bouadi N, Gemae M, Shahriari M (2025) Janus kinase inhibition in cutaneous histiocytosis: a systematic review. JAAD Review 3:18\u201320","DOI":"10.1016\/j.jdrv.2024.11.001"},{"issue":"1","key":"7164_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.anndiagpath.2013.10.003","volume":"18","author":"DP O'Malley","year":"2014","unstructured":"O\u2019Malley DP, Zuckerberg L, Smith LB, Barry TS, Gunn S, Tam W et al (2014) The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases. Ann Diagn Pathol 18(1):18\u201320. https:\/\/doi.org\/10.1016\/j.anndiagpath.2013.10.003","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"7164_CR69","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1097\/IOP.0000000000002670","volume":"40","author":"C Shi","year":"2024","unstructured":"Shi C, Lytle A, Milman T, Penne R, Bagg A (2024) Composite histiocytic sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma of the ocular adnexa. Ophthalmic Plast Reconstr Surg 40(5):e156\u2013e61. https:\/\/doi.org\/10.1097\/IOP.0000000000002670","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"7164_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/aje\/153.2.188","volume":"153","author":"BA Rybicki","year":"2001","unstructured":"Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J Jr., Chase GA et al (2001) Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 153(2):188\u201393. https:\/\/doi.org\/10.1093\/aje\/153.2.188","journal-title":"Am J Epidemiol"},{"issue":"2","key":"7164_CR71","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41433-020-0874-4","volume":"35","author":"K Vahdani","year":"2021","unstructured":"Vahdani K, Rose GE (2021) Sarcoid-like granulomatous orbitopathy-presentation, systemic involvement and clinical outcome. Eye (Lond) 35(2):470\u2013476. https:\/\/doi.org\/10.1038\/s41433-020-0874-4","journal-title":"Eye (Lond)"},{"issue":"2","key":"7164_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/IOP.0000000000001493","volume":"36","author":"K Vahdani","year":"2020","unstructured":"Vahdani K, Rose GE (2020) Predictive value of serum angiotensin-converting enzyme titers in sarcoid-like dacryoadenitis. Ophthalmic Plast Reconstr Surg 36(2):144\u2013147. https:\/\/doi.org\/10.1097\/IOP.0000000000001493","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"12","key":"7164_CR73","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/s0161-6420(95)30763-4","volume":"102","author":"WJ Power","year":"1995","unstructured":"Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS (1995) The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 102(12):2007\u20132011. https:\/\/doi.org\/10.1016\/s0161-6420(95)30763-4","journal-title":"Ophthalmology"},{"issue":"1","key":"7164_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","volume":"106","author":"S Dev","year":"1999","unstructured":"Dev S, McCallum RM, Jaffe GJ (1999) Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 106(1):111\u2013118. https:\/\/doi.org\/10.1016\/S0161-6420(99)90011-8","journal-title":"Ophthalmology"},{"issue":"5","key":"7164_CR75","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01676830.2022.2042826","volume":"42","author":"RA Gallo","year":"2023","unstructured":"Gallo RA, Zhang MG, Abou Khzam R, Tang VD, Dubovy SR, Rong AJ (2023) Osteolytic sarcoidosis of the orbit without pulmonary involvement. Orbit 42(5):548\u2013552. https:\/\/doi.org\/10.1080\/01676830.2022.2042826","journal-title":"Orbit"},{"issue":"3","key":"7164_CR76","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.3.e42","volume":"107","author":"KL Grogg","year":"2001","unstructured":"Grogg KL, Nascimento AG (2001) Subcutaneous granuloma annulare in childhood: clinicopathologic features in 34 cases. Pediatrics 107(3):E42. https:\/\/doi.org\/10.1542\/peds.107.3.e42","journal-title":"Pediatrics"},{"issue":"3","key":"7164_CR77","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archopht.1983.01040010418015","volume":"101","author":"MJ Ross","year":"1983","unstructured":"Ross MJ, Cohen KL, Peiffer RL Jr., Grimson BS (1983) Episcleral and orbital pseudorheumatoid nodules. Arch Ophthalmol 101(3):418\u201321. https:\/\/doi.org\/10.1001\/archopht.1983.01040010418015","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"7164_CR78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1525-1470.1994.tb00064.x","volume":"11","author":"MJ Evans","year":"1994","unstructured":"Evans MJ, Blessing K, Gray ES (1994) Pseudorheumatoid nodule (deep granuloma annulare) of childhood: clinicopathologic features of twenty patients. Pediatr Dermatol 11(1):6\u20139. https:\/\/doi.org\/10.1111\/j.1525-1470.1994.tb00064.x","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"7164_CR79","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1542\/peds.100.6.965","volume":"100","author":"EI Felner","year":"1997","unstructured":"Felner EI, Steinberg JB, Weinberg AG (1997) Subcutaneous granuloma annulare: a review of 47 cases. Pediatrics 100(6):965\u2013967. https:\/\/doi.org\/10.1542\/peds.100.6.965","journal-title":"Pediatrics"},{"issue":"5","key":"7164_CR80","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/COC.0b013e3182568fb6","volume":"36","author":"W Shi","year":"2013","unstructured":"Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT et al (2013) Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol 36(5):505\u20138. https:\/\/doi.org\/10.1097\/COC.0b013e3182568fb6","journal-title":"Am J Clin Oncol"},{"key":"7164_CR81","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819840000","author":"E Palmerini","year":"2019","unstructured":"Palmerini E, Picci P, Reichardt P, Downey G (2019) Malignancy in giant cell tumor of bone: a review of the literature. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/1533033819840000","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"7164_CR82","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1148\/radiographics.21.5.g01se251283","volume":"21","author":"MD Murphey","year":"2001","unstructured":"Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001) From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics 21(5):1283\u20131309. https:\/\/doi.org\/10.1148\/radiographics.21.5.g01se251283","journal-title":"Radiographics"},{"key":"7164_CR83","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/archsurg.1942.01210240043003","volume":"44","author":"HL Jaffe","year":"1942","unstructured":"Jaffe HL, Lichtenstein L (1942) Solitary unicameral bone cyst with emphasis on the roentgen picture, the pathologic appearance and the pathogenesis. Arch Surg 44:1004\u20131025. https:\/\/doi.org\/10.1001\/archsurg.1942.01210240043003","journal-title":"Arch Surg"},{"issue":"3","key":"7164_CR84","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2214\/ajr.164.3.7863874","volume":"164","author":"MJ Kransdorf","year":"1995","unstructured":"Kransdorf MJ, Sweet DE (1995) Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol 164(3):573\u2013580. https:\/\/doi.org\/10.2214\/ajr.164.3.7863874","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"7164_CR85","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MOP.0000000000001205","volume":"35","author":"TPG van Geloven","year":"2023","unstructured":"van Geloven TPG, van de Sande MAJ, van der Heijden L (2023) The treatment of aneurysmal bone cysts. Curr Opin Pediatr 35(1):131\u20137. https:\/\/doi.org\/10.1097\/MOP.0000000000001205","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"7164_CR86","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00590-021-02893-6","volume":"31","author":"GS Cruz","year":"2021","unstructured":"Cruz GS, Cuevas-Suarez CE, Saavedra JPA, Giorgis R, Teixeira MRK, Muniz F (2021) Percutaneous treatments of primary aneurysmal bone cysts: systematic review and meta-analysis. Eur J Orthop Surg Traumatol 31(7):1287\u20131295. https:\/\/doi.org\/10.1007\/s00590-021-02893-6","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"1","key":"7164_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105260","volume":"89","author":"J Maximen","year":"2022","unstructured":"Maximen J, Robin F, Tronchot A, Rossetti A, Ropars M, Guggenbuhl P (2022) Denosumab in the management of aneurysmal bone cyst. Joint Bone Spine 89(1):105260. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105260","journal-title":"Joint Bone Spine"},{"issue":"3","key":"7164_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archopht.1992.01080150076032","volume":"110","author":"SH Goldberg","year":"1992","unstructured":"Goldberg SH, Sassani JW, Parnes RE (1992) Traumatic intraconal hematic cyst of the orbit. Arch Ophthalmol 110(3):378\u2013380. https:\/\/doi.org\/10.1001\/archopht.1992.01080150076032","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"7164_CR89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3171\/jns.1978.48.2.0197","volume":"48","author":"H Ito","year":"1978","unstructured":"Ito H, Komai T, Yamamoto S (1978) Fibrinolytic enzyme in the lining walls of chronic subdural hematoma. J Neurosurg 48(2):197\u2013200. https:\/\/doi.org\/10.3171\/jns.1978.48.2.0197","journal-title":"J Neurosurg"},{"issue":"1","key":"7164_CR90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0161-6420(90)32632-5","volume":"97","author":"AA McNab","year":"1990","unstructured":"McNab AA, Wright JE (1990) Orbitofrontal cholesterol granuloma. Ophthalmology 97(1):28\u201332. https:\/\/doi.org\/10.1016\/s0161-6420(90)32632-5","journal-title":"Ophthalmology"},{"issue":"1","key":"7164_CR91","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1442-9071.2003.00605.x","volume":"31","author":"D Selva","year":"2003","unstructured":"Selva D, Phipps SE, O\u2019Connell JX, White VA, Rootman J (2003) Pathogenesis of orbital cholesterol granuloma. Clin Exp Ophthalmol 31(1):78\u201382. https:\/\/doi.org\/10.1046\/j.1442-9071.2003.00605.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"7164_CR92","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.IOP.0000083644.62765.70","volume":"19","author":"YO Arat","year":"2003","unstructured":"Arat YO, Chaudhry IA, Boniuk M (2003) Orbitofrontal cholesterol granuloma: distinct diagnostic features and management. Ophthalmic Plast Reconstr Surg 19(5):382\u2013387. https:\/\/doi.org\/10.1097\/01.IOP.0000083644.62765.70","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"7164_CR93","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/IOP.0b013e318137a6fe","volume":"23","author":"DR Jordan","year":"2007","unstructured":"Jordan DR, Spitellie P, Brownstein S, Rawlings N, Gilberg SM (2007) Orbital cholesterol granuloma and cholesteatoma: significance of differentiating the two. Ophthalmic Plast Reconstr Surg 23(5):415\u2013417. https:\/\/doi.org\/10.1097\/IOP.0b013e318137a6fe","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"7164_CR94","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archotol.1936.00640050467004","volume":"24","author":"RW Teed","year":"1936","unstructured":"Teed RW (1936) Cholesteatoma verum tympani: its relationship to the first epibranchial placode. Arch Otolaryngol 24:455\u2013474. https:\/\/doi.org\/10.1001\/archotol.1936.00640050467004","journal-title":"Arch Otolaryngol"},{"issue":"8 Pt 1","key":"7164_CR95","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1288\/00005537-198908000-00002","volume":"99","author":"KX McKennan","year":"1989","unstructured":"McKennan KX, Chole RA (1989) Post-traumatic cholesteatoma. Laryngoscope 99(8 Pt 1):779\u201382. https:\/\/doi.org\/10.1288\/00005537-198908000-00002","journal-title":"Laryngoscope"},{"issue":"1","key":"7164_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1442-9071.2000.00273.x","volume":"28","author":"D Selva","year":"2000","unstructured":"Selva D, Dolman PJ, Rootman J (2000) Orbital granulomatous giant cell myositis: a case report and review. Clin Exp Ophthalmol 28(1):65\u201368. https:\/\/doi.org\/10.1046\/j.1442-9071.2000.00273.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"7164_CR97","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/s0161-6420(90)32554-x","volume":"97","author":"JC Kattah","year":"1990","unstructured":"Kattah JC, Zimmerman LE, Kolsky MP, Chrousos G, Chavis R, Jaffe G et al (1990) Bilateral orbital involvement in fatal giant cell polymyositis. Ophthalmology 97(4):520\u20135. https:\/\/doi.org\/10.1016\/s0161-6420(90)32554-x","journal-title":"Ophthalmology"},{"issue":"3","key":"7164_CR98","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1212\/wnl.23.3.305","volume":"23","author":"JO Susac","year":"1973","unstructured":"Susac JO, Garcia-Mullin R, Glaser JS (1973) Ophthalmoplegia in dermatomyositis. Neurology 23(3):305\u2013310. https:\/\/doi.org\/10.1212\/wnl.23.3.305","journal-title":"Neurology"},{"issue":"1","key":"7164_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000246194","volume":"193","author":"G Mancuso","year":"1996","unstructured":"Mancuso G, La Regina G, Bagnoli M, Bittolo Bon G, Cazzolato G, Preda P et al (1996) Normolipidemic\u2019 tendinous and tuberous xanthomatosis. Dermatology 193(1):27\u201332. https:\/\/doi.org\/10.1159\/000246194","journal-title":"Dermatology"},{"issue":"3","key":"7164_CR100","first-page":"161","volume":"30","author":"Y Shukla","year":"1982","unstructured":"Shukla Y, Ratnawat PS (1982) Tuberous Xanthoma of upper eye lids (a case report). Indian J Ophthalmol 30(3):161\u2013162. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7174063. https:\/\/journals.lww.com\/ijo\/fulltext\/1982\/30030\/tuberous_xanthoma_of_upper_eye_lids.12.aspx","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"7164_CR101","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00002341-199606000-00006","volume":"12","author":"SE Katz","year":"1996","unstructured":"Katz SE, Rootman J (1996) Adverse effects of bone wax in surgery of the orbit. Ophthalmic Plast Reconstr Surg 12(2):121\u2013126. https:\/\/doi.org\/10.1097\/00002341-199606000-00006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"9","key":"7164_CR102","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0161-6420(03)00560-8","volume":"110","author":"AD Abel","year":"2003","unstructured":"Abel AD, Carlson JA, Bakri S, Meyer DR (2003) Sclerosing lipogranuloma of the orbit after periocular steroid injection. Ophthalmology 110(9):1841\u20131845. https:\/\/doi.org\/10.1016\/S0161-6420(03)00560-8","journal-title":"Ophthalmology"},{"issue":"4","key":"7164_CR103","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/01676830.2022.2025855","volume":"42","author":"C Wilde","year":"2023","unstructured":"Wilde C, Vahdani K, Thaung C, Rose GE (2023) Persistent orbital inflammation following complete excision of deep dermoid cysts. Orbit 42(4):434\u2013436. https:\/\/doi.org\/10.1080\/01676830.2022.2025855","journal-title":"Orbit"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07164-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:49:09Z","timestamp":1779428949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07164-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7164"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07164-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests that could have appeared to influence this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}